Clinical trials for breast cancer

80 currently recruiting clinical trials

Phase 3 Breast cancer
#NCT05514054
HER2 Negative HR Positive Localized None Hormone therapy
Hôpital Européen Georges Pompidou - AP-HP (Paris), Polyclinique de Blois (La Chaussée-Saint-Victor), Institut Sainte Catherine (Avignon), Clinique Chénieux (Limoges), Institut Bergonié (Bordeaux) (and 28 more...)
Eli Lilly et compagnie
Phase 3 Breast cancer
#NCT05501886
HER2 Negative HR Positive Locally Advanced Metastatic 1 2 Targeted therapy Hormone therapy Targeted therapy Hormone therapy
Systemic Treatment-Naive Chemotherapy Antibody Drug Conjugates (ADC)
Institut Bergonié (Bordeaux), Centre François Baclesse (Caen ), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Gustave Roussy (Villejuif), Hôpital de la Timone AP-HM (Marseille) (and 2 more...)
Celcuity, Inc
Phase 3 Breast cancer
#NCT05296798
HER2 Positive HR Positive Locally Advanced Metastatic 1
Immunotherapy Chemotherapy Targeted therapy Car-T Bispecific T-cell engager antibodies Antibody Drug Conjugates (ADC)
Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Institut Sainte Catherine (Avignon), Centre Hospitalier de la Côte Basque (Bayonne), Centre Hospitalier Universitaire de Besançon (Besançon), Polyclinique Bordeaux Nord Aquitaine (Bordeaux) (and 5 more...)
Hoffmann-La Roche
Phase 3 Breast cancer
#NCT04862663
HER2 Negative HR Positive Locally Advanced Metastatic 1 Hormone therapy
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Gustave Roussy (Villejuif), Hôpital Avicenne - AP-HP (Bobigny), Centre Hospitalier Universitaire Dupuytren (Limoges), Centre Léon Bérard (Lyon) (and 2 more...)
AstraZeneca
Phase 3 Breast cancer
#NCT06435429
HER2 Positive Locally Advanced Metastatic 1 2 3 or more Antibody Drug Conjugates (ADC)
Systemic Treatment-Naive
Institut du cancer de Montpellier (Montpellier), Centre de Cancerologie de la Sarthe (Le Mans), Hôpital de la Timone AP-HM (Marseille), Institut Bergonié (Bordeaux), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ) (and 6 more...)
Jazz Pharmaceuticals
Phase 3 Breast cancer
#NCT06312176
HER2 Negative HR Positive Locally Advanced Metastatic Targeted therapy Hormone therapy
Chemotherapy
Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon), Hôpital Privé du Confluent - Vivalto Santé (Nantes), Institut Curie - Paris (Paris), Centre François Baclesse (Caen ), Centre de Cancérologie du Grand Montpellier (Montpellier) (and 2 more...)
Merck Sharp & Dohme LLC
Phase 3 Breast cancer
#NCT02089100
HR Positive Metastatic Surgery Radiotherapy Systemic Treatment-Naive Surgery Radiotherapy
Hormone therapy
Gustave Roussy (Villejuif), Centre Eugene Marquis (Rennes)
Gustave Roussy, Campus du cancer, Grand Paris
Phase 3 Breast cancer
#NCT06065748
HER2 Negative HR Positive Locally Advanced Metastatic ESR Hormone therapy Systemic Treatment-Naive
Systemic Treatment-Naive
Centre François Baclesse (Caen ), Centre Jean Perrin (Clermont Ferrand ), Centre Eugene Marquis (Rennes), Centre Oscar Lambret (Lille), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ) (and 8 more...)
Hoffmann-La Roche
Phase 2 Breast cancer
#NCT06840483
HER2 Negative HR Positive Locally Advanced Metastatic 1 2 3 or more Hormone therapy
Antibody Drug Conjugates (ADC) Systemic Treatment-Naive Antibody Drug Conjugates (ADC)
Centre Eugene Marquis (Rennes)
BicycleTx Limited
Phase 2 Breast cancer
#NCT06840483
HER2 Negative HR Negative Locally Advanced Metastatic 1 2 3 or more
Antibody Drug Conjugates (ADC) Systemic Treatment-Naive Antibody Drug Conjugates (ADC)
Centre Eugene Marquis (Rennes)
BicycleTx Limited